The mission of the Birth Defects Initiative is to capitalize on genomic and other biomedical discoveries to further understanding of the mechanisms responsible for structural birth defects, which affect about 3% of all live births in the United States each year.
The ultimate goal of the initiative is the development of new, innovative, and valuable strategies for the molecular diagnosis, treatment, and prevention of human structural birth defects. It is led by the Developmental Biology and Structural Variation Branch (DBSVB).
Through the initiative, DBSVB supports basic scientists and clinicians whose research projects span basic, translational, and clinical approaches to understanding the developmental biology and genetics of structural birth defects.
- NICHD Contact: Reiko Toyama